Back in May, Emory Transplant Center announced that they, along with six other transplant centers and organizations in the Southeastern Kidney Transplant Coalition, were awarded $2.6 million by the National Institutes of Minority Health and Health Disparities to continue the Reducing Disparities in Access to Kidney Transplantation Community Study (RaDIANT) in Georgia for another five years and expand it to South Carolina and North Carolina.
We are excited to bring you the initial outcomes of the study. The results were published in the October issue of the Journal of the American Society of Nephrology. Rachel Patzer, PhD, MPH, assistant professor of surgery at Emory University School of Medicine, is first author, and Stephan Pastan, MD, medical director of the kidney and pancreas transplant program at Emory Transplant Center, is senior author.
The RaDIANT study is a multicomponent intervention designed to increase referral of patients on dialysis for transplant evaluation. In December 2013 the research team selected dialysis facilities with either low transplant referral or racial disparities in referral. The intervention, conducted from January to December 2014, included transplant education and engagement activities targeting dialysis facility leadership, staff and patients. These included talks at dialysis centers by former patients, and educational webinars for clinical staff about common barriers faced by patients and potential solutions.
The educational and outreach program in Georgia dialysis centers in 2014 resulted in a 75 percent increase in referrals for kidney transplant evaluation, with the greatest increase among black patients.
“This work could not have been done without our committed group of academic and community partners in our Southeastern Kidney Transplant Coalition”, says Patzer. ”The multicomponent educational and outreach intervention that our Coalition developed together substantially improved kidney transplant referral and reduced racial disparity, and we are working to adapt it for use by other ESRD networks and other members of the kidney community.”